Akari Therapeutics PLC (AKTX) SEC Filings — 2025

Filings

• Akari Therapeutics PLC 8-K Filing — 8-K · Dec 17, 2025
• Akari Therapeutics Files 8-K on Shareholder Votes & Financials — 8-K · Dec 16, 2025
• Akari Therapeutics PLC 8-K Filing — 8-K · Dec 8, 2025
• Akari Therapeutics Faces Delisting Concerns — 8-K · Nov 26, 2025
• Akari Therapeutics Seeks Share Restructuring, Warrant Approval — DEF 14A · Nov 17, 2025
• Akari Narrows Loss to $12M, But Intangible Impairment Hits Q3 — 10-Q · Nov 13, 2025
• Akari Therapeutics Files 8-K: Officer/Director Changes & Financials — 8-K · Oct 23, 2025
• Akari Therapeutics Files 8-K: Material Agreement & Equity Update — 8-K · Oct 16, 2025
• Akari Therapeutics Files 8-K — 8-K · Oct 15, 2025
• Akari Therapeutics to Acquire 03 Life Sciences — 8-K · Sep 29, 2025
• Akari Therapeutics Enters Material Definitive Agreement — 8-K · Sep 25, 2025
• Akari Therapeutics Files 8-K: Agreements, Equity Sales, and Board Changes — 8-K · Aug 29, 2025
• Akari Therapeutics Enters and Terminates Agreements — 8-K · Aug 21, 2025
• Akari Therapeutics PLC 8-K Filing — 8-K · Aug 19, 2025
• Akari Narrows Losses, Shifts Focus to ADC Platform Post-Peak Bio Merger — 10-Q · Aug 13, 2025
• Akari Therapeutics Files 8-K: Officer Changes & Shareholder Votes — 8-K · Jul 1, 2025
• Akari Therapeutics Details Equity-Heavy Executive Pay in DEF 14A — DEF 14A · Jun 6, 2025
• Akari Therapeutics Files 8-K on Financials — 8-K · May 15, 2025
• Akari Therapeutics Plc Files 10-Q for Q1 2025 — 10-Q · May 14, 2025
• Akari Therapeutics Files 8-K on Operations — 8-K · Apr 16, 2025
• Akari Therapeutics Plc Files 2024 10-K — 10-K · Apr 15, 2025
• Akari Therapeutics Announces Director Changes — 8-K · Mar 20, 2025
• Akari Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 3, 2025
• Akari Therapeutics Plc Files 8-K — 8-K · Jan 13, 2025